Design and statistical optimization of osmotically driven capsule based on push-pull technology

Pharmaceutical Development and Technology

Volumn 18, Issue 2, 2013, Pages 515-524

  Shaikh, Wasim ^a   Deshmukh, Prashant K ^a   Patil, Ganesh B ^a   Chatap, Vivekanand K ^a   Bari, Sanjay B ^a  

^a H R PATEL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

Author keywords

Mannitol; Osmotically activated; Statistical optimization; Valsartan

Indexed keywords

GELATIN; VALSARTAN;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG CAPSULE; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; IN VITRO STUDY; INFRARED SPECTROSCOPY; OSMOSIS; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TABLET;

CALORIMETRY, DIFFERENTIAL SCANNING; CAPSULES; CHEMISTRY, PHARMACEUTICAL; EXCIPIENTS; GELATIN; KINETICS; MEMBRANES, ARTIFICIAL; OSMOSIS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TABLETS; TECHNOLOGY, PHARMACEUTICAL; TETRAZOLES; VALINE;

EID: 84872457854     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450.2012.726999     Document Type: Article

References (29)

1. Prescott LF. (1989). The need for improved drug delivery in clinical practice. In: Novel Drug Delivery and its Therapeutic Application. West Susset, U.K.: John Wiley and Sons, 1-11
2. Makhija SN, Vavia PR. Controlled porosity osmotic pump-based controlled release systems of pseudoephedrine. I. Cellulose acetate as a semipermeable membrane. J Control Release 2003; 89:5-18 (Pubitemid 36416615)
3. Theeuwes F. Elementary osmotic pump. J Pharm Sci 1975;64: 1987-1991
4. Gupta S, Singh RP, Sharma R, Kalyanwat R, Lokwani P. Osmotic pumps: A review. Int J Comp Pharm 2011;2:1-8
5. Santus G, Baker RW. Osmotic drug delivery: A review of the patent literature. J Control Release 1995;35:1-21
6. Prabakaran D, Singh P, Kanaujia P, Jaganathan KS, Rawat A, Vyas SP. Modified push-pull osmotic system for simultaneous delivery of theophylline and salbutamol: Development and in vitro characterization. Int J Pharm 2004;284:95-108 (Pubitemid 39349143)
7. Liu L, Ku J, Khang G, Lee B, Rhee JM, Lee HB. Nifedipine controlled delivery by sandwiched osmotic tablet system. J Control Release 2000;68:145-156 (Pubitemid 30488892)
8. Wong PSL, Barclay BL, Deters JC, Theeuwes F. Osmotic device for administering certain drugs. US Patent 4765989; 1986:1-65
9. Waterman KC, Goeken GS, Konagurthu S, Likar MD, MacDonald BC, Mahajan N et al. Osmotic capsules: A universal oral, controlled-release drug delivery dosage form. J Control Release 2011;152:264-269
10. Thombre AG, Cardinal JR, DeNoto AR, Gibbes DC. Asymmetric membrane capsules for osmotic drug delivery II. In vitro and in vivo drug release performance. J Control Release 1999;57:65-73 (Pubitemid 29005074)
11. Thombre AG, Cardinal JR, DeNoto AR, Herbig SM, Smith KL. Asymmetric membrane capsules for osmotic drug delivery. I. Development of a manufacturing process. J Control Release 1999;57:55-64 (Pubitemid 29005073)
12. Herbig SM, Cardinal JR, Korsmeyer RW, Smith KL. Asymmetricmembrane tablet coatings for osmotic drug delivery. J Controlled Release 1995;35:127-136
13. Barzegar-Jalali M, Adibkia K, Mohammadi G, Zeraati M, Bolagh BA, Nokhodchi A. Propranolol hydrochloride osmotic capsule with controlled onset of release. Drug Deliv 2007;14:461-468 (Pubitemid 350125740)
14. Choudhury PK, Ranawat MS, Pillai MK, Chauhan CS. Asymmetric membrane capsule for osmotic delivery of flurbiprofen. Acta Pharm 2007;57:343-350 (Pubitemid 47429184)
15. Philip A, Pathak K. In situ-formed asymmetric membrane capsule for osmotic release of poorly water-soluble drug. PDA J Pharm Sci Technol 2007;61:24-36 (Pubitemid 46355541)
16. Wang CY, Ho HO, Lin LH, Lin YK, Sheu MT. Asymmetric membrane capsules for delivery of poorly water-soluble drugs by osmotic effects. Int J Pharm 2005;297:89-97
17. Malaterre V, Ogorka J, Loggia N, Gurny R. Approach to design push-pull osmotic pumps. Int J Pharm 2009;376:56-62
18. Malaterre V, Ogorka J, Loggia N, Gurny R. Evaluation of the tablet core factors influencing the release kinetics and the loadability of push-pull osmotic systems. Drug Dev Ind Pharm 2009;35:433-439
19. Gupta V, Verma S, Nanda A, Nanda S. Osmotically controlled drug delivery: Review. Drug Del Technol 2005;5:68-76
20. Gurrapu A, Jukanti R, Bobbala SR, Kanuganti S, Jeevana JB. Improved oral delivery of valsartan from maltodextrin based proniosome powders. Adv Powder Technol 2011;23:583-590
21. Brookman LJ, Rolan PE, Benjamin IS, Palmer KR, Wyld PJ, Lloyd P et al. Pharmacokinetics of valsartan in patients with liver disease. Clin Pharmacol Ther 1997;62:272-278 (Pubitemid 27417792)
22. Mehtap S, Sevgi T. Bioavailability file: Valsartan. FABAD J Pharm Sci 2007;32:185-196
23. Prabakaran D, Singh P, Kanaujia P, Vyas SP. Effect of hydrophilic polymers on the release of diltiazem hydrochloride from elementary osmotic pumps. Int J Pharm 2003;259:173-179 (Pubitemid 36638563)
24. Najib N, Suleiman MS. The kinetics of drug release from ethyl cellulose solid dispersions. Drug Dev Ind Pharm 1985;11:2169-2181 (Pubitemid 16207535)
25. Desai SJ, Singh P, Simonelli AP, Higuchi WI. Investigation of factors influencing release of solid drug dispersed in inert matrices. 3 Quantitative studies involving the polyethylene plastic matrix. J Pharm Sci 1966;55:1230-1234
26. Higuchi T. Mechanism of sustained-action medication. theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 1963;52:1145-1149
27. Hixson AW, Crowell JH. Dependence of reaction velocity upon surface and agitation (I) theoretical consideration. Ind Eng Chem 1931;23:923-931
28. Korsenmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanism of solute release from porous hydrophilic polymers. Int J Pharm 1983;15:25-35 (Pubitemid 13092121)
29. Singhvi G, Singh M. In-vitro drug release characterization models: Review. Int J Pharm Stud Res 2011;2:77-84